ÂÜÀòÂÒÂ×

Margaret is committed to the translation of innovative biological approaches into viable patient care.

With over ten years’ international research experience, she specialises in virology and leads the scientific teams in the discovery of powerful new oncolytic viruses for clinical development.

Previously a Fellow with the Kay Kendall Leukaemia Fund at the University of Oxford, Margaret also spent several years as a Postdoctoral Researcher with the University of Glasgow and with Batavia Biosciences in Leiden as part of the Marie Curie Industry-Academia Partnerships programme.

Margaret has a PhD in Adenoviral Gene Therapy from the University of Glasgow.